Aug 2026
In vivo CAR‑T therapy: recent progress and future directions
In vivo CAR-T is poised to broaden the reach of cellular immunotherapy, provided that its development is guided by rigorous pharmacology, chemistry, manufacturing and controls, and long-term molecular safety surveillance.
Wan-Ting Wang, Yujia Cai, Xuanming Yang et al.
· Immunity & Inflammation · 0 citations